Skip to main content

Patents and Industrial Design


Protecting Technical Innovation and Product Design
From patent strategy and design protection to commercialization and enforcement, Fasken helps organizations secure, manage, and leverage patents and industrial designs to support innovation, market position, and long‑term growth in Canada and internationally.
Subscribe Fasken
Share
  • LinkedIn

Overview

Patents and industrial designs protect the technical innovation and product features that differentiate business offerings in competitive markets. Whether developing new technologies, launching products, or entering cross‑border transactions, organizations need coordinated IP advice that aligns protection, commercialization, and enforcement. Fasken helps clients manage patent and design assets strategically throughout their lifecycle.

Patents and Industrial Design in a Competitive Innovation Landscape

Patents and industrial designs play a central role in protecting innovation, enabling commercialization, and supporting transactions. Early decisions around drafting, filing, and portfolio structure can have lasting commercial consequences. At the same time, businesses must manage freedom‑to‑operate risk, monitor competitors, and prepare for enforcement where necessary.

Fasken supports clients across industries and jurisdictions, helping them protect technical innovation and product design while aligning IP strategy with business objectives.

What You Can Expect

  • Strategic patent and design advice aligned with innovation and growth plans
  • Technically informed drafting and prosecution to support enforceability and value
  • Proactive portfolio management and competitive landscape monitoring
  • Integrated support for licensing, transactions, and commercialization
  • Practical guidance on enforcement, disputes, and regulatory considerations

Who We Serve

Technology and Product‑Driven Companies — Organizations developing new technologies, devices, platforms, and products that rely on patent and design protection.

Life Sciences, Medical, and Regulated Industries — Clients operating in highly regulated sectors where patents and designs intersect with pricing, compliance, and approval regimes.

Manufacturers and Design‑Led Businesses — Companies for whom product appearance, configuration, and functionality are critical to market differentiation.

Innovators, Start‑Ups, and Growth Companies — Businesses seeking scalable IP strategies as they move from development to commercialization and expansion.

Types of Matters We Handle

Patent and Industrial Design Strategy: IP planning, portfolio structuring, filing strategies, and lifecycle management.

Drafting, Prosecution, and Registration: Preparation and prosecution of patent and industrial design applications in Canada and coordination internationally.

Competitive Landscape and Freedom‑to‑Operate Analysis: Monitoring competitor activity, patentability assessments, and freedom‑to‑operate opinions.

Commercialization and Transactions: Licensing, distribution, R&D agreements, joint ventures, and IP support in M&A and financings.

Enforcement and Dispute Resolution: Infringement proceedings, defence of claims, and coordination with IP litigation teams.

Regulatory and Administrative Proceedings: Representation before bodies such as the Patented Medicine Prices Review Board (PMPRB).

Cross‑Border Patent and Design Matters: Coordinated international protection and enforcement with trusted global counsel.

Why Clients Choose Fasken

Clients choose Fasken for patent and industrial design advice that combines technical depth with commercial judgment. We understand how early drafting decisions affect enforceability, transactions, and long‑term value, and we tailor strategies accordingly.

Fasken’s patent and industrial design practice is consistently recognized by independent legal directories and industry publications, reflecting sustained involvement in complex, innovation‑driven IP matters.

What Success Looks Like

Patent Portfolio Development: Developed and managed a patent portfolio supporting the commercialization of a new technology platform.

Design Protection Strategy: Advised a product‑driven business on industrial design protection to support market differentiation and enforcement.

Transaction Support: Supported patent and design diligence and licensing arrangements as part of a cross‑border acquisition.

Regulatory Proceedings: Represented clients before the PMPRB in matters affecting patented pharmaceutical products.

Court Proceedings: represented many clients in complex and high stakes patent litigation, with a winning record.

Frequently Asked Questions (FAQs)

Q: Do you advise on both patents and industrial designs?
A:
Yes. We regularly advise on the protection and management of both patents and industrial designs, often in parallel.

Q: Can you help assess freedom‑to‑operate risk?
A:
Yes. We provide freedom‑to‑operate and competitive landscape analysis to support product development and commercialization.

Q: Do you support cross‑border patent strategies?
A:
Absolutely. We coordinate international filing, prosecution, and enforcement strategies with trusted counsel worldwide.

Q: Do you assist with enforcement and disputes?
A:
Yes. We work closely with our IP Litigation team to support enforcement and defence of patent and design rights.

Your Team at Fasken

Our lawyers and patent agents support across the full lifecycle of innovation, from early‑stage development and portfolio strategy to commercialization, transactions, and enforcement.

The team includes professionals with advanced training in engineering, life sciences, pharmaceuticals, and other technical disciplines. Clients value our ability to translate complex technology into clear, enforceable IP rights and to coordinate seamlessly with litigation, regulatory, and transactional colleagues when patents and designs are central to broader business objectives.

Achievements

  • Recognized as international leaders in Patent law, Lexology Index 2018 to 2024
  • Thought Leaders in Patent Litigation, Lexology Index 2020 to 2022
  • Recommended by LMG Life Sciences in Patent Litigation, LMG Life Sciences 2022

Team

Primary Contacts
  • Alain M. Leclerc, Partner | Trademark Agent | Patent Agent | IP Litigation, Montréal, QC, +1 514 397 4321, [email protected]
  • Armand M. Benitah, Partner | Patent Agent | Trademark Agent | Trademarks Law, Toronto, ON, +1 416 868 3470, [email protected]
Alain M. Leclerc, Partner | Trademark Agent | Patent Agent | IP Litigation Alain M. Leclerc Partner | Trademark Agent | Patent Agent | IP Litigation Montréal, QC +1 514 397 4321
Armand M Benitah Toronto Lawyer Armand M. Benitah Partner | Patent Agent | Trademark Agent | Trademarks Law Toronto, ON +1 416 868 3470
+1 418 640 2050

Experience

  • Echelon Wealth Partners Inc. leads C$2.36 million financing for VOTI Detection Inc., [Deal - Echelon Wealth Partners Inc.], Private placement for Canadian x-ray security system company
  • Québec Court of Appeal confirms unconstitutionality of certain amendments to the Patented Medicines Regulations which govern the PMPRB federal patented drug pricing regime, [Case - Merck and al.], Fasken successfully represented a coalition of major pharmaceutical companies before the Quebec Superior Court and Quebec Court of Appeal to confirm the unconstitutionality and invalidity of certain amendments to the Patented Medicines Regulations which govern the PMPRB federal patented drug pricing regime.
  • Echelon Wealth Partners Inc. leads C$5.75 million brokered financing for ProStar Holdings Inc., [Deal - Echelon Wealth Partners Inc.], C$5.75 million private placement for data collection and GIS mapping software company.
  • Echelon Wealth Partners Inc. leads C$10 million financing for VOTI Detection Inc, [Deal - Echelon Wealth Partners Inc.], $4.3 million private placement for Canadian x-ray security system company.
  • Echelon Wealth Partners Inc. leads $10 million financing for Boardwalktech Software Corp, [Deal - Echelon Wealth Partners Inc.], $10 million private placement for emerging blockchain-based data management company
  • BRP wins major lawsuit against competitor Arctic Cat, [Case - Bombardier Recreational Products Inc.], In a lawsuit launched in December 2011, Bombardier Recreational Products accused its major competitor Arctic Cat of infringing BRP’s patents related to its revolutionary Ski-Doo REV snowmobiles. BRP is a global leader in snowmobiles, power sports vehicles and propulsion systems with over 75 years...
  • Constitutional challenge in the Superior Court of Québec attacking controversial amendments to the Patented Medicines Regulations and the validity of the existing PMPRB regime under the Patent Act, [Case - Merck Canada Inc., Janssen Inc., Servier Canada Inc., Boehringer Ingelheim Canada Ltd/Ltée, Bayer Canada Inc., Theratechnologies Inc., and an additional (Confidential) pharmaceutical company], Constitutional challenge in the Superior Court of Québec.
  • Thermolec Ltée sued Stelpro Inc. and Stelpro Design Inc. for patent infringement, [Case - Thermolec Ltée], Fasken began this case with a successful motion for an interlocutory injunction to prohibit the production and sale of the infringing products until expiry of the patent. This is a rare and noteworthy outcome, one that was commented on by several other law firms. Interlocutory injunctions in pa...
  • FICPI represented at Supreme Court hearing regarding “Promise Doctrine”, [Case - International Federation of Intellectual Property Attorneys (FICPI)], AstraZeneca holds patent 2,139,653 (patent “653”), which claims the optically pure salts of esomeprazole, a proton pump inhibitor used in the reduction of gastric acid, in particular reflux esophagitis. Apotex applied to the federal Minister of Health for a Notice of Compliance, allowing it to se...

Knowledge

  • New PMPRB Draft Guidelines Set Out Administrative Process for Excessive Price Hearing Recommendation, 12/30/2024
  • Federal Court of Appeal Rules That PMPRB Has No Jurisdiction Over Unpatented Medicine Prices: The End of the “Slender Thread” Test, 12/9/2024
  • Williams v Music and Entertainment Rights Licensing Independent Network Ltd and the Territorial Principle, 8/9/2024
  • Patent Term Adjustment is finally coming to Canada, 7/16/2024
  • Blacklock’s Reporter v Canada (Attorney General) and Password Sharing for Research Purposes, 6/26/2024
  • Copyright and Presentations: How to Avoid Presentation-Related Copyright Infringement, 4/30/2024
  • Alberta et al v Canadian Copyright Licensing Agency (Access Copyright), 2024 FC 292 and the Voluntary Copyright Tariff Regime, 4/26/2024
  • Doan v Clearview Inc and the Identification of Class Members, 2/5/2024
  • Voltage Holdings, LLC v Doe #1 and Evidentiary Requirements in Copyright Infringement, 2/1/2024
  • Opposition and Cancellation Proceedings Shifting Into Higher Gear in Canada, 12/5/2023

Events

  • Life Sciences Patent Strategies, 5/27/2026
  • Europe in Motion: What Canadian Businesses Need to Know About Trends in Intellectual Property, 4/14/2026
  • Protecting AI Investment – Leveraging Patent Protection for your Innovations, 3/11/2026
  • How to Protect Your Branding: Taking Action Against Counterfeiting Online and in Pop-up Markets, 2/21/2024
  • Choosing legally winning brands, 4/26/2023

News

  • Christian Leblanc analyzes the legal framework surrounding AI-generated artistic content in an interview broadcast on 98.5, 3/25/2026
  • Fasken to Participate in the 2026 Québec Agtech Symposium, 3/25/2026
  • Thirteen Fasken lawyers recognized as IP Stars by Managing Intellectual Property, 8/4/2021
  • Fasken Partners Recognized in the 2021 World IP Review Leaders Guide, 5/11/2021
  • Fourteen Fasken lawyers recognized as IP Stars by Managing Intellectual Property, 6/22/2020
  • IAM Patent 1000 2017 and IAM Strategy 300 Guides Name 9 Fasken Martineau Partners, 6/21/2017
  • InHouse Magazine quotes David Turgeon in an article about the newly signed Comprehensive Economic and Trade Agreement, 2/6/2017
  • Who’s Who Legal: Canada 2016: 68 Fasken Martineau lawyers ranked, 11/4/2016
  • Fasken Martineau’s client BRP wins a favourable judgement in the Federal Court of Canada, 9/30/2016
  • CBC News quotes Ariel Thomas in an article about PayPal cutting ties with a major unblocking company, 2/17/2016

    Subscribe

    Receive email updates from our team about Intellectual Property